Dejun Luo Selected Research

Tolperisone

1/2020	Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].
5/2017	The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dejun Luo Research Topics

Disease

2	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 05/2017
1	Pain (Aches) 01/2022
1	Intervertebral Disc Displacement (Herniated Disc) 01/2022
1	Necrosis 11/2010

Drug/Important Bio-Agent (IBA)

2	Baclofen FDA LinkGeneric 01/2020 - 05/2017
2	TolperisoneIBA 01/2020 - 05/2017
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Escherichia coli endotoxinIBA 11/2010
1	SteroidsIBA 11/2010
1	osteokingIBA 11/2010
1	Prednisolone (Predate)FDA LinkGeneric 11/2010

Therapy/Procedure

1	Moxibustion 01/2022
1	Aftercare (After-Treatment) 01/2022